Ceftazidime-resistant isolates of Escherichia coli and KlebsieUla pneumoniae produced a plasmid-mediated a-lactamase with a pI of 5.6 with biochemical characteristics comparable to those of the TEM-10 13-lactamase. Plasmids from the two strains were nonidentical. Both TEM-10 sequences differed from TEM-1 by substitutions of Ser-162 and Lys-237. The nucleotide sequences of the two genes were identical except for three silent nucleotide substitutions corresponding to the nucleotide differences in the Tn2 TEM-1 or Tn3 TEM-1 genes. The original TEM-10 plasmid was identical to that found in the E. coli isolate and coded for a gene that corresponded to the TEM-10 P-lactamase from Tn2.
was found to be common among some of these isolates.
Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli were recovered from 50 patients with infections, predominantly of the urinary tract, who were hospitalized at Michael Reese Hospital between November 1990 and October 1992 (17, 18) . Thirty of the 50 infections (60%) were acquired before hospital admission; 87% of these were acquired in seven different nursing homes. The following two representative isolates were examined in detail: a hospital-acquired K pneumoniae strain (strain 2351) and a nursing home-acquired E. coli strain (strain 2585).
The isoelectric focusing (IEF) patterns of the isolates differed in that K pneumoniae 2351 produced two 3-lactamases with pIs of 5.6 and 7.6, whereas E. coli 2585 produced enzymes with pIs of 5.4 and 5.6 ( Fig. 1 (Fig. 1) . The P-lactamase with a pI of 5.6 was purified from E. coli 2351T (a transconjugant of K pneumoniae 2351) by using Sephadex G75 and boronic acid affinity chromatography (10) . A reference preparation of the * Corresponding author.
TEM-10 ,-lactamase from K pneumoniae KC2 was purified in the same manner (10 (Fig. 2) . The original TEM-10 ,B-lactamase-producing strain K pneumoniae KC2 (10) pCLL2304. As shown in Table 2 , all three P-lactamase genes appeared to be derived from a TEM-1 gene, showing the same two base changes that occurred at positions 692 and 917. The resulting amino acid changes of Ser-162 for Arg-162 and Lys-237 for Glu-237 in TEM-1 are the same as those reported for the TEM-10 sequence from pJPQ100 (7) and the TEM-23 sequence (16) . These changes are consistent with those reported previously for ceftazidime-hydrolyzing 3-lactamases, in which a substitution of Lys at either position 237 or 102, together with Ser-162, allows the enzyme to accept aminothiazole oxime-substituted 3-lactams as good substrates (5, 14) . Surprisingly, two different TEM-10 genes were observed, with three silent nucleotide substitutions at positions 226, 436, and 604 ( Table 2 ). The sequence of the 3-lactamase gene from pCLL2304 was identical to the sequence of the P-lactamase gene from the original TEM-10 plasmid pJPQ100 and appeared to be derived from the TEM-1 gene of Tn2 (2, 4) . In contrast, the TEM-10 gene from pCLL2303 appeared to originate from the TEM-1 gene of Tn3 on the basis of the three silent nucleotide substitutions between the TEM-1 gene of Tn2 and the TEM-1 gene of Tn3.
From these results, it is apparent that the TEM-10 3-lactamase has reappeared in Chicago on at least two different plasmids, one of which is the same as that found in the original TEM-10-producing isolates. The apparent difference in TEM-1 origins is particularly noteworthy and suggests that the amino acid changes associated with ceftazidime hydrolysis resulted from two different genetic events. The observation that an extended-spectrum 1-lactamase plasmid may be present in an outpatient population shows that these genes may be maintained in the absence of hospital pressures and that extended-spectrum ,-lactamase-producing organisms are no longer confined to nosocomial infections.
